Glenn Sblendorio - 22 Jun 2023 Form 4 Insider Report for IVERIC bio, Inc.

Role: Chief Executive Officer, Director
Signature: /s/ David Carroll, as Attorney-in-Fact for Glenn P. Sblendorio
Issuer symbol: N/A
Transactions as of: 22 Jun 2023
Net transactions value: +$146,486
Form type: 4
Filing time: 26 Jun 2023, 16:44:48 UTC
Previous filing: 12 Jun 2023
Next filing: 13 Jul 2023
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	ISEE	Common Stock	Options Exercise	$146,486	+11,084	+4.9%	$13.22	239,275	22 Jun 2023	Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	ISEE	Stock Option (right to buy)	Options Exercise	$0	-11,084	-100%	$0.000000^*	0	22 Jun 2023	Common Stock	11,084	$13.22	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	This option was granted on July 9, 2013 under the Registrant's 2007 Stock Incentive Plan and vested in monthly increments for a period of 36 months from the date of the grant.